In today’s biotech landscape, capital is scarce and pipelines are strong - yet many companies struggle to deliver.
The difference increasingly lies in organizational tenacity: the ability to adapt, reskill and execute under continuous pressure.
This panel challenges where true bottlenecks sit and explores how learning velocity determines which companies turn funding into sustainable value.
Monday, May 4, 16:30 - 17:15, room Kairo
| Name | Position | Institution |
|---|---|---|
| Eva Perez Casesmeiro | Head DDIT US&I Marketing & Customer Engagement | Novartis |
| Name | Position | Institution |
|---|---|---|
| Sarah Holmes-Klotz | CHRO | Santhera |
| Melanie Rolli | Former Group CEO, Boardmember & Advisor | Helsinn |
| Alan Rankin | CPO | Moderna |
| Annett Zippel | Partner | KennedyFitch |
KennedyFitch is a partner-led collective specialised in Executive Search, People Advisory and Leadership and Transformation. We work with organisations who want to create impact by building future-fit leadership, strong cultures and people strategies that support sustainable performance. We collaborate on leadership development and people strategy, including cohort programs like “From Scientific Expert to People Leader” at the SwissBiotech Academy, in-house journeys and thought leadership.
